Literature DB >> 19937420

Upper gastrointestinal promotility drugs: not all uniform?

Rita Brun, Braden Kuo.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19937420     DOI: 10.1007/s12664-009-0045-9

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


× No keyword cloud information.
  19 in total

1.  Effects of a 5-HT(4) receptor agonist on oesophageal function and gastro-oesophageal reflux: studies using combined impedance-manometry and combined impedance-pH.

Authors:  R Tutuian; I Mainie; R Allan; K Hargreaves; A Agrawal; J Freeman; J Gale; D O Castell
Journal:  Aliment Pharmacol Ther       Date:  2006-07-01       Impact factor: 8.171

2.  Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro.

Authors:  E M Jarvie; V J North Laidler; S Corcoran; A Bassil; G J Sanger
Journal:  Br J Pharmacol       Date:  2007-01-08       Impact factor: 8.739

Review 3.  Review article: tegaserod.

Authors:  M Camilleri
Journal:  Aliment Pharmacol Ther       Date:  2001-03       Impact factor: 8.171

4.  Effect of tegaserod on gut transit in male and female subjects.

Authors:  L Degen; C Petrig; D Studer; S Schroller; C Beglinger
Journal:  Neurogastroenterol Motil       Date:  2005-12       Impact factor: 3.598

5.  A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation.

Authors:  J Tack; S Müller-Lissner; P Bytzer; R Corinaldesi; L Chang; A Viegas; S Schnekenbuehl; C Dunger-Baldauf; P Rueegg
Journal:  Gut       Date:  2005-07-14       Impact factor: 23.059

6.  Effects of tegaserod and erythromycin in upper gut dysmotility: a comparative study.

Authors:  Issam Nasr; Satish S C Rao; Ashok Attaluri; Syed M A Hashmi; Robert Summers
Journal:  Indian J Gastroenterol       Date:  2009-11-24

Review 7.  5-HT4 receptor agonists: similar but not the same.

Authors:  J H De Maeyer; R A Lefebvre; J A J Schuurkes
Journal:  Neurogastroenterol Motil       Date:  2008-02       Impact factor: 3.598

8.  The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin.

Authors:  R D Richards; K Davenport; R W McCallum
Journal:  Am J Gastroenterol       Date:  1993-02       Impact factor: 10.864

Review 9.  Gastrointestinal problems in diabetes.

Authors:  M Camilleri
Journal:  Endocrinol Metab Clin North Am       Date:  1996-06       Impact factor: 4.741

Review 10.  Systemic prokinetic pharmacologic treatment for postoperative adynamic ileus following abdominal surgery in adults.

Authors:  U Traut; L Brügger; R Kunz; C Pauli-Magnus; K Haug; H C Bucher; M T Koller
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.